Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

NCT03671603 · clinicaltrials.gov ↗

COMPLETED

Status

2755

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
ST-segment Elevation Myocardial Infarction

Interventions

DRUG: Iodixanol

Sponsor

GE Healthcare